NO20072633L - Kjemisk prosess - Google Patents

Kjemisk prosess

Info

Publication number
NO20072633L
NO20072633L NO20072633A NO20072633A NO20072633L NO 20072633 L NO20072633 L NO 20072633L NO 20072633 A NO20072633 A NO 20072633A NO 20072633 A NO20072633 A NO 20072633A NO 20072633 L NO20072633 L NO 20072633L
Authority
NO
Norway
Prior art keywords
processes
chemical process
dyslipidemias
manifestations
enzymatic
Prior art date
Application number
NO20072633A
Other languages
English (en)
Norwegian (no)
Inventor
David Brown
John Peter Gilday
Philip Anthony Hopes
Jonathan David Moseley
Evan William Snape
Andrew Wells
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20072633L publication Critical patent/NO20072633L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P11/00—Preparation of sulfur-containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/52—Propionic acid; Butyric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20072633A 2004-12-16 2007-05-24 Kjemisk prosess NO20072633L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0427524.4A GB0427524D0 (en) 2004-12-16 2004-12-16 Chemical process
PCT/GB2005/004800 WO2006064213A2 (en) 2004-12-16 2005-12-14 Chemical process

Publications (1)

Publication Number Publication Date
NO20072633L true NO20072633L (no) 2007-06-21

Family

ID=34090119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072633A NO20072633L (no) 2004-12-16 2007-05-24 Kjemisk prosess

Country Status (17)

Country Link
US (1) US7803586B2 (ja)
EP (1) EP1828394A2 (ja)
JP (1) JP2008523797A (ja)
KR (1) KR20070094908A (ja)
CN (1) CN101080495A (ja)
AR (1) AR052054A1 (ja)
AU (1) AU2005315454A1 (ja)
BR (1) BRPI0518948A2 (ja)
CA (1) CA2588591A1 (ja)
GB (1) GB0427524D0 (ja)
IL (1) IL183524A0 (ja)
MX (1) MX2007007219A (ja)
NO (1) NO20072633L (ja)
SA (1) SA05260405A (ja)
TW (1) TW200636071A (ja)
UY (1) UY29271A1 (ja)
WO (1) WO2006064213A2 (ja)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011072A1 (en) 1999-08-05 2001-02-15 Novo Nordisk A/S Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids
JP2003506065A (ja) * 1999-08-05 2003-02-18 ノボ ノルディスク アクティーゼルスカブ 置換された３−フェニル−プロパン酸エステル及び置換された３−フェニル−プロパン酸の調製の方法
SE0104333D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0314130D0 (en) 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314075D0 (en) 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314131D0 (en) 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314260D0 (en) 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
WO2006064213A2 (en) 2006-06-22
TW200636071A (en) 2006-10-16
AU2005315454A1 (en) 2006-06-22
EP1828394A2 (en) 2007-09-05
IL183524A0 (en) 2007-09-20
AR052054A1 (es) 2007-02-28
WO2006064213A3 (en) 2006-08-24
UY29271A1 (es) 2006-07-31
CN101080495A (zh) 2007-11-28
SA05260405A (ar) 2005-12-03
BRPI0518948A2 (pt) 2008-12-16
US7803586B2 (en) 2010-09-28
US20080115247A1 (en) 2008-05-15
GB0427524D0 (en) 2005-01-19
MX2007007219A (es) 2007-08-14
CA2588591A1 (en) 2006-06-22
JP2008523797A (ja) 2008-07-10
KR20070094908A (ko) 2007-09-27

Similar Documents

Publication Publication Date Title
BRPI1005683A2 (pt) processo livre de células in vitro de produção de um ácido desoxirribonucleio (dna) linear fechado, kit, método de indução de reação imunológica contra um antígeno em um hospedeiro, processo de elaboração de uma composição farmacêutica e uso de uma molécula de dna linear fechado na fabricação de um medicamento
NO20076055L (no) Imidazo- og triazolopyridiner som inhibitorer av 11-beta-hydroksysteroid-dehydrogenase type I
NO20076054L (no) Imidiazo - og triazolopyridiner som inhibitorer av 11-beta-hydroksysteroid-dehydrogenase type I
DE502006006107D1 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
NO20082834L (no) 2-(fenyl eller heterosyklisk)-1H-fenantro[9,10-D]imidazoler som MPGES-1-inhibitorer
NO20044436L (no) Substituerte fenyleddiksyrer
NI201400027A (es) 1 - pirazolil - 3 - ( 4 - (( 2 - anilinopirimidin - 4 - il) oxi) naftalen - 1 - il) ureas como inhibidores de proteínas cinasas activadas por mitógeno p38
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
NO20091588L (no) Kjemisk prosess
NO20065535L (no) Behandling av respiratorisk sykdom
BR112014005581A2 (pt) compostos inibidores de enzima
NO20083003L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for a senke lipider og blodglykosenivaer
NO20065453L (no) Fenoksyalkykarboksylsyrederivater i behandlingen av inflammatoriske sykdommer.
JP2011162558A5 (ja)
CO6640286A2 (es) Proceso in vitro para la determinacion rapida en un paciente del estado de infeccion con mycrobacterium tuberculosis
BR112015005416A2 (pt) produção de ácidos orgânicos por meio de fermentação em baixo ph
BR112012018385A2 (pt) indução e estabilização de atividade enzimática em micro-organismos
Ma et al. Small molecules in the big picture of gut microbiome-host cross-talk
BR112014031934A8 (pt) Método com base em euglobulina para determinar a atividade biológica de defibrotide
NO20081082L (no) Nye piperidinderivater som kjemokinreseptorformulatorer som er nyttige for behandling av respiratoriske sykdommer
Dawadi et al. Synthesis and analysis of bacterial folate metabolism intermediates and antifolates
CY1117790T1 (el) Ενωσεις αναστολεα 11-βητα-υδροξυστεροειδους αφυδρογονασης τυπου 1
NO20074639L (no) Krystallinsk base av trans-1-((1R,3S)-6-klor-3-fenylindan-1-yl)-3,3-dimetylpiperazin
Sgarbi et al. Human NARP mitochondrial mutation metabolism corrected with α-ketoglutarate/aspartate: a potential new therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application